Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine in Relapsed and Refractory Multiple Myeloma
NCT00412919Phase 2Terminated
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in multiple myeloma (MM). Started Dec 2006; status: terminated.
02
Drugs
azacitidine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00412919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412919.